Costs and benefits of measles and mumps immunization in Austria.
The usefulness of an immunization programme can be evaluated by comparing either risks and benefits or costs and benefits. By means of special formulae, the benefit-cost ratio and the benefit-cost difference can be calculated for monovalent and bivalent vaccines. An analysis of combined measles-mumps immunization in Austria showed that this measure is highly profitable economically. Since employed mothers are allowed one week's vacation each year to nurse a sick child, this affects the calculations. Including the cost of the "nursing vacation" among the benefits that would be realized following an immunization programme, the estimated benefit-cost ratio is 4.48; if the cost of the "nursing vacation" is omitted the ratio is 2.65. The estimated annual benefit-cost differences are AS 1681.90 and AS 672.85, respectively, per child. Twelve years after the beginning of a programme to immunize 100 000 1-year-old children per year (corresponding roughly to the birth rate in Austria) an amount of AS 528 million would be saved if the "nursing vacation" is included in the calculations and an amount of AS 63 million if it is not.
D001317:Austria; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D007114:Immunization / Q000191:economics*; D007115:Immunization Schedule; D008297:Male; D008457:Measles / Q000517:prevention & control*; D009107:Mumps / Q000517:prevention & control*; D009313:National Health Programs / Q000191:economics